MYC and cancer: Our findings contradicted the previous studies because in the DBTRG-05MG brain cancer cell line after andrographolide treatment, c-Myc was overexpressed to inhibit the cancer cell, as can be supported well with our WST-1, scratch, and clonogenic assays.